2025-08-21
New Breakthrough! Milk Transforms into “Living Material” in Seconds, a Novel Biogel is Born
The top - tier international materials journal Matter has published online the groundbreaking research findings of a joint team from Columbia University and the University of Padua. This study is the first to systematically disclose how to utilize bovine - derived extracellular vesicles (EVs) extracted from yogurt whey, a by - product of milk processing, to construct bioactive injectable hydrogels with dynamic cross - linking properties. This innovative technology offers a new paradigm for resolving the dual challenges of “injectability” and “maintenance of biological activity” in the field of tissue engineering.
2025-08-15
Good News! Three Organoid Cryopreservation Technologies of Our Team Accepted for National Patents
In the era of rapid development of organoid research, achieving long - term stable preservation while maintaining biological activity and functional integrity remains a crucial bottleneck restricting the clinical translation of this technology and its application in drug R & D. Recently, three technological inventions by the research team of Yinfeng Low - Temperature Medical Research Center were accepted by the National Intellectual Property Administration. These three technologies focus on the challenges of organoid cryopreservation and cover the key steps in the entire process of organoid vitrification preservation, offering a more efficient and reliable solution for safeguarding biological samples in organoid research.
2025-08-15
Researchers from Johns Hopkins University in the United States recently announced the successful cultivation of the world's first “whole - brain” organoid that contains neural tissues from multiple brain regions and preliminary vascular structures. The relevant findings were published in the journal Advanced Science. This groundbreaking research offers a brand - new experimental model for exploring the mechanisms of complex neuropsychiatric diseases like autism and schizophrenia and for drug development.
2025-07-21
In recent years, significant progress has been made in gene therapy for genetic diseases. In particular, the ex - vivo gene therapy strategy based on lentiviral vectors has been successfully applied to diseases such as severe combined immunodeficiency caused by adenosine deaminase deficiency (ADA - SCID). However, existing therapies still face challenges such as high toxic side effects of chemotherapy pre - treatment, complex operations, and high costs, and have limited efficacy for diseases involving multiple tissues.
2025-07-21
Recently, led by the Center for Excellence in Brain Science and Intelligence Technology of the Chinese Academy of Sciences, in collaboration with top domestic research institutions such as the Suzhou Institute of Brain - like Intelligence, Huazhong University of Science and Technology, and the BGI Life Sciences Research Institute, and in cooperation with scientific teams from countries like France, Sweden, and the UK, a significant breakthrough has been made in brain science research.
2025-07-11
A Russian research team has recently published a groundbreaking achievement. By combining density functional theory (DFT) calculations with experimental verification, they successfully uncovered the molecular mechanism of sucrose molecules in cryopreservation, presenting a brand - new strategy for optimizing the freeze - drying process of biological samples and for biological cryopreservation. This research not only resolves the long - standing problem of ice - crystal damage that has troubled cryobiology but also initiates an interdisciplinary research paradigm of "theoretical calculations guiding experimental design".
2025-07-11
An international research team composed of four top - tier institutions, namely Cincinnati Children's Hospital, Icahn School of Medicine at Mount Sinai, Tokyo Institute of Science, and Takeda Pharmaceutical Company, has achieved a revolutionary breakthrough in the field of organoid technology. The team published their latest research findings in Nature Biomedical Engineering, successfully cultivating liver organoids with a functional vascular network, which paves a new way for the treatment of hemophilia and liver regenerative medicine.
2025-07-03
On June 25, 2025, the team led by Professor Wang Huiying and Dr. Jin Bo from Shenzhen Hospital of Beijing University of Chinese Medicine collaborated with Shandong Yinfeng Life Science Research Institute to develop the "ovarian dual activation" technology. Through this technology, patients with POI (primary ovarian insufficiency) underwent intra - operative freeze - thaw activation of ovarian tissue. After intra - operative transplantation, a baby was born, and both the mother and the baby are healthy and safe.
2025-06-27
Recently, the team led by Alison Marsden from Stanford University in the United States published a significant breakthrough in the journal Science. They successfully developed a computational model that can rapidly design the vascular network for 3D - printed organs. This technology is expected to greatly reduce the manufacturing time of artificial organs and offer new solutions to the problem of organ transplantation shortage.
Yinfeng Life Continuation Plan
Address: Yinfeng Biotechnology Park, 1758 Gangyuan 6th Road, High-tech Zone, Jinan City, Shandong Province
Zip Code: 250102
Telephone: 0086-0531-88897351
Mobile: 0086-19953155507
Mobile website
Official WeChat Public Number
Links:Red Cross Society of China丨Shandong Red Cross Society丨Shandong Provincial Health Commission | Yinfeng Group| Yinfeng Biological Group
All rights reserved©Yinfeng Life Continuation Powered by www.300.cn SEO
